NY S00927 | 2023-2024 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on January 9 2023 - 25% progression
Action: 2024-01-03 - REFERRED TO INSURANCE
Pending: Senate Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 9 2023 - 25% progression
Action: 2024-01-03 - REFERRED TO INSURANCE
Pending: Senate Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.
Title
Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2024-01-03 | Senate | REFERRED TO INSURANCE |
2023-01-09 | Senate | REFERRED TO INSURANCE |
Same As/Similar To
A09075 (Same As) 2024-02-06 - referred to insurance